Press Releases

Date Title and Summary
Toggle Summary Capnia Regains Compliance With NASDAQ Listing Standards
REDWOOD CITY, Calif. , Jan. 12, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it received written correspondence from The NASDAQ Stock Market
Toggle Summary Capnia Closes Second Tranche of Private Placement of Convertible Preferred Stock
REDWOOD CITY, Calif. , Jan. 11, 2016 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that it has closed the $5.4 million second tranche of its
Toggle Summary Capnia Granted Orphan Designation for Nasal CO2 for the Treatment of Trigeminal Neuralgia
REDWOOD CITY, Calif. , Dec. 21, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced that the U.S. Food and Drug Administration ( FDA ) has granted Orphan
Toggle Summary Capnia Reports Third Quarter 2015 Financial Results
REDWOOD CITY, Calif. , Nov. 12, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), a diversified healthcare company that develops innovative diagnostics, devices and therapeutics addressing unmet medical needs, today announced financial results for the third quarter ended September 30, 2015 .
Toggle Summary Capnia Announces Private Placement of Up to $10 Million of Convertible Preferred Stock and Warrants
REDWOOD CITY, Calif. , Oct. 12, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel diagnostic and therapeutic products based on its proprietary technologies for precision metering of gas flow, today announced that it has entered into an
Toggle Summary Capnia to Participate at Upcoming Investor Conferences
REDWOOD CITY, Calif. , Sept. 30, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering of gas flow, today announced its participation in two upcoming investor conferences: The Aegis 2015 Growth
Toggle Summary Capnia Announces Publication of CoSense(R) Clinical Data in the Journal Neonatology
Study Demonstrates Superiority of CoSense in Detecting Hemolysis and Reducing Jaundice-Related Readmissions REDWOOD CITY, Calif. , Sept. 24, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development of novel products based on its proprietary technologies for precision metering
Toggle Summary Capnia Acquires Neonatal Pulmonary Resuscitation Solutions From NeoForce Group, Inc.
Acquisition Strengthens Capnia's Presence in Neonatology NeoForce President and Chief Executive Officer to Join Capnia as General Manager of Neonatology REDWOOD CITY, Calif. , Sept. 8, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel
Toggle Summary Capnia to Present at Rodman & Renshaw 17th Annual Global Investment Conference
REDWOOD CITY, Calif. , Sept. 2, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced that Anish Bhatnagar , M.D., Chief Executive Officer,
Toggle Summary Capnia Reports Second Quarter 2015 Financial Results
REDWOOD CITY, Calif. , Aug. 7, 2015 (GLOBE NEWSWIRE) -- Capnia, Inc. (NASDAQ:CAPN), focused on the development and commercialization of novel products based on its proprietary technologies for precision metering of gas flow, today announced financial results for the second quarter ended June 30,